Document:

exv10w1

Exhibit 10.1

TECHNOLOGY LICENSE AND ESCROW AGREEMENT

This Technology License and Escrow Agreement (“License”) effective June 15, 2010 is
made by and between ThermoGenesis Corp., a Delaware corporation (“ThermoGenesis”), and Cbr Systems,
Inc., a California corporation (“CBR”).

BACKGROUND

A. ThermoGenesis and CBR entered into a Product Development and Supply Assurances Agreement dated
August 14, 2006 (the “Product Agreement”), under which ThermoGenesis agreed to develop and
manufacture a new AXP disposable and to assure the supply and availability of the AXP System and
Processing Sets (the “Products”), as defined in the Product Agreement. The Products are sold to
CBR pursuant to a Sale and Purchase Agreement dated August 18, 2006 (“Supply Agreement”) by and
between CBR and GE Healthcare Bio-Sciences AB (“GEHC”). GEHC holds the exclusive right to sell and
distribute the AXP System in the United States.

B. ThermoGenesis and CBR intend by this License to license and make available to CBR (through an
escrow arrangement) certain technical information for the limited purpose of allowing CBR, only
upon a Default (as defined below), to have the Products manufactured.

NOW, THEREFORE, the parties agree as follows:

1. Escrow Deposit.

     (a) Initial Deposit. ThermoGenesis agrees during the term of the Product Agreement to
deposit a complete description of all information and know-how that is required or useful for the
manufacture of the Products, including but not limited to technical information, vendor lists,
costing documents, engineering drawings, manufacturing and assembly SOPS, and related information,
including that contained in the currently approved and released ThermoGenesis Device Master Record
(“DMR”, as defined in 21 CFR 820.181), with a technology escrow service mutually acceptable to
ThermoGenesis and CBR (“Escrow Company”). ThermoGenesis and CBR have initially selected Iron
Mountain Intellectual Property Management, Inc. to serve as the Escrow Company pursuant to the
terms of the Three Party Master Beneficiary Escrow Service Agreement by and among ThermoGenesis,
CBR and Iron Mountain (“Escrow Agreement”), in the form attached as Exhibit A.
ThermoGenesis will determine the exact materials that need to be deposited into escrow
(“Deposit Materials”). The Deposit Materials shall be ready for deposit to escrow within fourteen
(14) days from the date of this Agreement.

     (b) Supplemental Deposits. ThermoGenesis agrees to supplement the Deposit Materials
at least once in each six (6) month period from the effective date to incorporate any additions to
or modifications of the technical information and know-how necessary to manufacture the Products.
At the time of deposit of such a supplement, ThermoGenesis shall provide to CBR an updated
officer’s certificate as provided in paragraph 1(a) above. The supplement and all previous
deposits shall be available for verification by CBR as provided in paragraph 1(a) above.

2. Assistance. In the event of a Default (as defined below) by ThermoGenesis,
ThermoGenesis agrees to timely provide to CBR the technical assistance and assistance with its
vendors, suppliers, contractors and subcontractors that is required or useful to enable CBR to
manufacture the Products.

3. Escrow Agreement. ThermoGenesis and CBR agree to enter into the Escrow Agreement with
Escrow Company to serve as the escrow holder of the Deposit Materials, to provide certain
verification services and to release the Deposit Materials to CBR in the event that ThermoGenesis
fails to meet

 

 

anyone of the following covenants (a “Default”).

     (a) Cash flow positive for the month ended December 31, 2010, calculated as the
average of cash flows from the preceding three months, and all subsequent month-end
three-month rolling averages, as confirmed by ThermoGenesis management within 20 days
following any month end, unless ThermoGenesis is in compliance with provisions (b) and (c)
below, in which case there shall not be a Default; provided, however, that at any
month-end where the three-month rolling average of negative cash flow is otherwise allowed
under this section, such cash flow amount multiplied by negative nine must not exceed the
cash balance and short-term investments net of debt or borrowed funds; or

     (b) Cash balance and short-term investments net of debt or borrowed funds of not less
than Six Million Dollars ($6,000,000) at any month end, as confirmed by ThermoGenesis
management within 20 days following any month end; or

     (c) Quick ratio of not less than 2:1 at any month end, as confirmed by ThermoGenesis
Management within 20 days following any month end.

4. Appointment of Neutral to Determine Default. In the event that CBR believes that
ThermoGenesis is in Default, CBR shall provide written notice to ThermoGenesis of such default.
If the Default cannot be cured or if the cure is unsatisfactory to CBR, CBR may immediately
thereafter request release of the escrow materials. Either party may thereafter request binding
arbitration with Judicial Arbitration and Mediation Services, Inc. (“JAMS”) on the single issue
of whether CBR is entitled to a release of the Deposit Materials to CBR. The decision of JAMS
shall be rendered within thirty (30) days after the request for arbitration. The provisions of
Section 6.8 of the Product Agreement shall apply and are incorporated herein by this reference,
except to the extent that they conflict with the provisions of this paragraph 4. If the
arbitrator decides that CBR is entitled to a release of the Deposit Materials to CBR, the Deposit
Materials shall be released to CBR immediately.

5. Grant of Non-Exclusive License. ThermoGenesis hereby grants to CBR a royalty-free,
non-exclusive perpetual license to all intellectual property rights, technical information, and
know-how required to have the Products manufactured for the sole and limited purpose of
manufacturing and supplying the products for use by CBR. This license includes all and any
additions to or modifications of the technical information and know-how necessary to manufacture
the Products through the date of any release from Escrow. This license shall be non-transferable
(other than in a change of control of CBR or ThermoGenesis), provided that CBR may grant a
sublicense to a party to manufacture the Products, which sublicense shall be non-transferable,
non-sublicensable, and shall be subject to a confidentiality and non-disclosure agreement in the
form attached as Exhibit B.

6. Covenant Not to Exercise License Rights; Limitations. CBR shall not have the right to
exercise its license rights under paragraph 5 of this License, to use the intellectual property
rights, technical information, and know-how required to have the Products manufactured for the sole
and limited purpose of manufacturing and supplying the products for use by CBR, unless the Deposit
Materials are released to CBR as provided in paragraph 4 above.

7. Covenant Not to Interfere with Contractual Relations. ThermoGenesis covenants that it
has no arrangements, and shall create no arrangements, that would interfere with, hinder or
impede the ability
of its vendors, suppliers, contractors or subcontractors to work with and/or provide products to
CBR in the event of the occurrence of a Default.

8. Bankruptcy. In the event ThermoGenesis seeks or is involuntarily placed under the
protection of the bankruptcy laws, Title XI, U.S. Code, and the trustee in bankruptcy rejects this
Agreement, CBR hereby elects, pursuant to Section 365(n), to retain all rights granted to it under
this License.

 

 

9.  Notices.

	 	 	 

	     If to ThermoGenesis:

	 	ThermoGenesis Corp.

2711 Citrus Road

Rancho Cordova, CA 95742

Attn: Chief Executive Officer
	 
	 	 
	     With a copy to:

	 	David C. Adams, Esq.

Weintraub Genshlea Chediak

400 Capitol Mall, Suite 1100

Sacramento, CA 95814
	 
	 	 
	     If to CBR:

	 	Cbr Systems, Inc.

Attn: General Counsel

1200 Bayhill Drive, Suite #301

San Bruno, CA 94066
	 
	 	 
	     And:

	 	Cbr Systems, Inc.

Attn: Chief Executive Officer

6550 S. Bay Colony Drive

Tucson, AZ 85706
	 
	 	 
	     With a copy to:

	 	Thomas Chaffin, Esq.

Pillsbury Winthrop Shaw Pittman LLP

2475 Hanover Street

Palo Alto, CA 94304

10. No Amendment. This License does not amend, replace or supersede the Product Agreement,
except that the last sentence of Section 4.3 of the Product Agreement shall be amended to read, “In
the event that GEHC and ThermoGenesis terminate, cancel or otherwise fail to renew their
distribution agreement, ThermoGenesis shall assume the CBR/GEHC Sale and Purchase Agreement
(attached hereto as an exhibit) and its obligations in its entirety.

11. Miscellaneous. The Miscellaneous provisions in paragraphs 6.1-6.4 and 6.7-6.8 of the
Product Agreement shall apply to this License and are incorporated herein by this reference, except
to the extent that paragraph 6.8 (Binding Arbitration before JAMS) is modified by paragraph 3 of
this License.

12. No Waiver. A waiver by either party of a breach of any of the terms of this Agreement
by the other party shall not be deemed a waiver of any subsequent breach of the terms of this
Agreement. Furthermore, a party’s delay in enforcing its rights under this Agreement shall not be
deemed a waiver of such rights.

[Signature Page Follows]

 

 

     The parties have caused this instrument to be executed by their duly authorized
representatives, effective as of the day and year first above written.

	 	 	 	 	 
	 	THERMOGENESIS CORP.

 	 
	 Dated:  06/15/2010  	By:  	/s/ Mel Engle
 	 
	 	 	Name:  	Mel Engle 	 
	 	 	Title:  	President 	 
	 
	 	CBR SYSTEMS, INC.

 	 
	 Dated:  06/08/2010  	By:  	/s/ Joy Burke
 	 
	 	 	Name:  	Joy Burke 	 
	 	 	Title:  	General Counselexv4w1

Exhibit 4.1

     Unless this certificate is presented by an authorized representative of The Depository
Trust Company, a New York corporation (the “Depository”), to the Company or its agent for
registration of transfer, exchange, or payment, and any certificate issued is registered in the
name of Cede & Co. or in such other name as is requested by an authorized representative of the
Depository (and any payment is made to Cede & Co. or to such other entity as is requested by an
authorized representative of the Depository), ANY TRANSFER, PLEDGE, OR OTHER USE HEREOF FOR VALUE
OR OTHERWISE BY OR TO ANY PERSON IS WRONGFUL inasmuch as the registered owner hereof, Cede & Co.,
has an interest herein.

					
	 	 	 	 	 
	REGISTERED
	 	 	 	REGISTERED
	 
	 	CNA FINANCIAL CORPORATION	 	 
	 
	 	5.75% NOTE DUE August 15, 2021	 	 
	 
	 	 	 	CUSIP 126117AR1
	 
	 	 	 	ISIN US126117AR10
	 
	 	 	 	Common Code 056300139
	No. 001
	 	 	 	US$400,000,000

     CNA FINANCIAL CORPORATION, a corporation duly organized and existing under the laws of the
State of Delaware (the “Company”, which term includes any successor corporation under the Indenture
hereinafter referred to), for value received, hereby promises to pay to Cede & Co., or registered
assignees, the principal sum of Four Hundred Million Dollars ($400,000,000) on August 15, 2021, and
to pay interest thereon from and including February 14, 2011, or from the most recent Interest
Payment Date to which interest has been paid or duly provided for, semi-annually on February 15 and
August 15 of each year, commencing August 15, 2011, at the rate of 5.75% per annum, until the
principal hereof becomes due and payable, and at such rate on any overdue principal and (to the
extent that the payment of such interest shall be legally enforceable) on any overdue installment
of interest. The interest so payable, and punctually paid or duly provided for, on any Interest
Payment Date will, as provided in such Indenture, be paid to the Person in whose name this Security
(or one or more Predecessor Securities) is registered at the close of business on the Regular
Record Date for such interest payment, which shall be the February 1 or August 1 (whether or not a
Business Day), as the case may be, prior to the applicable Interest Payment Date. Any such
interest not so punctually paid or duly provided for shall forthwith cease to be payable to the
registered Holder on such Regular Record Date by virtue of his having been such Holder, and may
either be paid to the Person in whose name this Security (or one or more Predecessor Securities) is
registered at the close of business on a Special Record Date for the payment of such Defaulted
Interest to be fixed by the Trustee, notice whereof shall be given to Holders of Securities of this
series not less than 10 days prior to such Special Record Date, or be paid at any time in any other
lawful manner not inconsistent with the requirements of any securities exchange on which the
Securities of this series may be listed, and upon such notice as may be required by such exchange,
all as more fully provided in said Indenture.

     Payment of the principal of (and premium, if any) and interest on this Security will be in
immediately available funds, in such coin or currency of the United States of America as at the
time of payment is legal tender for payment of public and private debts.

     Unless the certificate of authentication herein has been duly executed by the Trustee referred
to herein by manual signature, this Security shall not be entitled to any benefit under the
Indenture or be valid or obligatory for any purpose.

     This security is one of a duly authorized issue of securities of the Company (the
“Securities”), issued or to be issued in one or more series under an indenture, dated as of March
1, 1991, as amended and supplemented by a first supplemental indenture, dated as of October 15,
1993, and a second supplemental indenture, dated as of December 15, 2004 (collectively, the
“Indenture”), between the Company and The Bank of New York Mellon Trust Company, N.A., as successor
in interest to J. P. Morgan Trust Company, National Association (formerly known as The First
National Bank of Chicago), a national banking association, as trustee (the “Trustee”, which term
includes any successor Trustee under the Indenture), to which Indenture and all indentures
supplemental thereto reference is hereby made for a statement of the respective rights, limitations
of rights, duties and immunities thereunder of the Company, the Trustee and the Holders of the
Securities and of the terms upon which the Securities are, and are to

 

 

be, authenticated and delivered. This Security is one of the series designated “5.75% Notes
due August 15, 2021”, and is limited, subject to the provisions of the Indenture, initially in
aggregate principal amount to $400,000,000. The Company may, from time to time, without the
consent of the Holders of the Securities of this series, reopen this series and issue additional
Securities.

     The Securities of this series will be redeemable, in whole or in part, at the Company’s option
at any time, at a redemption price (the “Redemption Price”) equal to the greater of (i) 100% of the
principal amount of the Securities of this series and (ii) the sum of the present values of the
remaining scheduled payments of principal and interest on the Securities of this series (exclusive
of interest accrued to the date of redemption (the “Redemption Date”)) discounted to the Redemption
Date on a semi-annual basis (assuming a 360-day year consisting of twelve 30-day months) at the
Treasury Rate plus 35 basis points, plus accrued and unpaid interest thereon to, but not including,
the Redemption Date.

     “Treasury Rate” means, with respect to any Redemption Date, the rate per annum equal to the
semi-annual equivalent yield to maturity or interpolated (on a day count basis) of the Comparable
Treasury Issue, assuming a price for the Comparable Treasury Issue (expressed as a percentage of
its principal amount) equal to the Comparable Treasury Price for such Redemption Date. The
Treasury Rate shall be calculated on the third business day preceding the Redemption Date.

     “Comparable Treasury Issue” means, with respect to the Securities of this series, the United
States Treasury security or securities selected by an Independent Investment Banker as having an
actual or interpolated maturity comparable to the remaining term of the Securities of this series
to be redeemed that would be utilized, at the time of selection and in accordance with customary
financial practice, in pricing new issues of corporate debt securities of a comparable maturity to
the remaining term of such Securities.

     “Independent Investment Banker” means one of the Reference Treasury Dealers appointed by the
Company.

     “Comparable Treasury Price” means, with respect to any Redemption Date, (A) the average of the
Reference Treasury Dealer Quotations for such Redemption Date, after excluding the highest and
lowest such Reference Treasury Dealer Quotations, or (B) if the Trustee is given fewer than four
such Reference Treasury Dealer Quotations, the average of all such quotations.

     “Reference Treasury Dealer Quotations” means, with respect to each Reference Treasury Dealer
and any Redemption Date, the average, as determined by the Trustee, of the bid and asked prices for
the Comparable Treasury Issue (expressed in each case as a percentage of its principal amount)
quoted in writing to the Trustee by such Reference Treasury Dealer at 3:30 p.m. New York time on
the third business day preceding such Redemption Date.

     “Reference Treasury Dealer” means each of J.P. Morgan Securities LLC, Merrill Lynch and
Pierce, Fenner & Smith Incorporated and a Primary Treasury Dealer (as defined below) selected by
Wells Fargo Securities, LLC, and their respective successors and one other Primary Treasury Dealer
selected by the Company; provided, however, that if any of the foregoing or their affiliates shall
cease to be a primary U.S. Government securities dealer in The City of New York (a “Primary
Treasury Dealer”), the Company shall substitute therefor another Primary Treasury Dealer.

     Notice of any redemption will be mailed at least 30 days but not more than 60 days before the
Redemption Date to each Holder of Securities of this series to be redeemed.

     Unless the Company defaults in payment of the Redemption Price, on and after the Redemption
Date interest will cease to accrue on the Securities of this series or portions thereof called for
redemption.

     If an Event of Default with respect to the Securities of this series shall have occurred and
be continuing, the principal of all the Securities of this series may be declared due and payable
in the manner and with the effect provided in the Indenture.

 

 

     In addition to the covenants contained in the Indenture, the Company hereby covenants and
agrees that it will not, and will not permit any Subsidiary to, create, assume, incur or permit to
exist any indebtedness for borrowed money (including any guarantee of indebtedness for borrowed
money) that is secured by a pledge, lien or other encumbrance on:

	 	(a)	 	the voting securities of The Continental Corporation, Continental
Casualty Company, The Continental Insurance Company, Continental Assurance Company,
CNA Surety Corporation or CNA National Warranty Corporation, or any Subsidiary
succeeding to any substantial part of the business now conducted by any of those
corporations (collectively, the “Principal Subsidiaries”), or
	 
	 	(b)	 	the voting securities of a Subsidiary that owns, directly or
indirectly, the voting securities of any of the Principal Subsidiaries,

without making effective provision so that the Outstanding Securities of this series shall be
secured equally and ratably with the indebtedness so secured so long as such other indebtedness
shall be secured. This covenant and agreement by the Company constitutes an agreement of the
Company in respect of the Securities of this series within the meaning of Section 5.1(d) of the
Indenture.

     For purposes of the preceding paragraph, “Subsidiary” means any corporation, partnership or
other entity of which at the time of determination the Company or one or more other Subsidiaries
own directly or indirectly more than 50% of the outstanding shares of the Voting Stock or
equivalent interest, and “Voting Stock” means stock which ordinarily has voting power for the
election of directors, whether at all times or only so long as no senior class of stock has such
voting power by reason of any contingency.

     The Indenture permits, with certain exceptions as therein provided, the amendment thereof and
the modification of the rights and obligations of the Company and the rights of the Holders of the
Securities to be affected under the Indenture at any time by the Company and the Trustee with the
consent of the Holders of not less than a majority in aggregate principal amount of the outstanding
Securities to be affected. The Indenture also contains provisions permitting the Holders of
specified percentages in aggregate principal amount of the Securities of any series at the time
Outstanding, on behalf of the Holders of all the Securities of such series, to waive compliance by
the Company with certain provisions of the Indenture and certain past defaults under the Indenture
and their consequences. Any such consent or waiver by the Holder of this Security shall be
conclusive and binding upon such Holder and upon all future Holders of this Security and of any
Security issued upon the registration of transfer hereof or in exchange herefor or in lieu hereof,
whether or not notation of such consent or waiver is made upon this Security.

     Holders of Securities may not enforce their rights pursuant to the Indenture or the Securities
except as provided in the Indenture. No reference herein to the Indenture and no provision of this
Security or of the Indenture shall alter or impair the obligation of the Company, which is absolute
and unconditional, to pay the principal of (and premium, if any) and interest on this Security at
the times, place and rate, and in the coin or currency, herein prescribed.

     The Securities of this series are issuable in registered form without coupons in minimum
denominations of $2,000 and any integral multiple of $1,000. As provided in the Indenture and
subject to certain limitations therein set forth, Securities of this series are exchangeable for a
like aggregate principal amount of Securities of this series of different authorized denominations,
as requested by the Holder surrendering the same.

     As provided in the Indenture and subject to certain limitations therein set forth, the
transfer of this Security is registrable on the Security Register of the Company, upon surrender of
this Security for registration of transfer at the office or agency of the Company in the Borough of
Manhattan, the City and State of New York, duly endorsed by, or accompanied by a written instrument
of transfer in form satisfactory to the Company, the Security Registrar and the Trustee and duly
executed by the Holder hereof or his attorney duly authorized in writing, thereupon one or more new
Securities of this series, of authorized denominations and for the same aggregate principal amount
will be issued to the designated transferee or transferees.

 

 

     This Security is in the form of a Global Security as provided in the Indenture. If at any
time the Depository notifies the Company that it is unwilling or unable to continue as Depository
for this Security or if at any time the Depository for this Security shall no longer be eligible or
in good standing under the Securities Exchange Act of 1934, as amended, or other applicable statute
or regulation, the Company shall appoint a successor Depository with respect to this Security. If
a successor Depository for this Security is not appointed by the Company within 90 days after the
Company receives notice or becomes aware of such ineligibility, the Company will execute, and the
Trustee or its agent, upon receipt of a Company Request for the authentication and delivery of
certificates representing Securities of this series in exchange for this Security, will
authenticate and deliver, certificates representing Securities of this series of like tenor and
terms in an aggregate principal amount equal to the principal amount of this Security in exchange
for this Security.

     The Company may at any time and in its sole discretion determine that this Security or portion
hereof shall no longer be represented in the form of a Global Security. In such event the Company
will execute, and the Trustee, upon receipt of a Company Request for the authentication and
delivery of certificates representing Securities of this series in exchange in whole or in part for
this Security, will authenticate and deliver certificates representing Securities of this series of
like tenor and terms in definitive form in an aggregate principal amount equal to the principal
amount of this Security or portion hereof in exchange for this Security.

     If specified by the Company pursuant to the Indenture with respect to this Security, the
Depository may surrender this Security in exchange in whole or in part for certificates
representing Securities of this series of like tenor and terms in definitive form on such terms as
are acceptable to the Company and the Depository. Thereupon the Company shall execute, and the
Trustee or its agent shall authenticate and deliver, without a service charge, (1) to each Holder
specified by the Security Registrar or the Depository a certificate or certificates representing
Securities of this series of like tenor and terms and of any authorized denomination as requested
by such person in an aggregate principal amount equal to and in exchange for such Holder’s
beneficial interest as specified by the Security Registrar or the Depository in this Security; and
(2) to the Depository a new Global Security of like tenor and terms and in an authorized
denomination equal to the difference, if any, between the principal amount of the surrendered
Security and the aggregate principal amount of certificates representing Securities delivered to
Holders thereof.

     No service charge shall be made for any such registration of transfer or exchange, but the
Company may require payment of a sum sufficient to cover any tax or other governmental charge
payable in connection therewith.

     Prior to due presentment of this Security for registration or transfer, the Company, the
Trustee and any agent of the Company or the Trustee may treat the Person in whose name this
Security is registered as the owner hereof for all purposes, whether or not this Security be
overdue, and neither the Company, the Trustee nor any such agent shall be affected by notice to the
contrary.

     No recourse shall be had for the payment of the principal of or interest on this Security, or
for any claim based hereon, or otherwise in respect hereof, or based on or in respect of the
Indenture or any indenture supplemental thereto, against any incorporator, stockholder, officer or
director, as such, past, present or future, of the Company or of any successor corporation, whether
by virtue of any constitution, statute or rule of law, or by the enforcement of any assessment or
penalty or otherwise, all such liabilities being, by the acceptance hereof and as part of the
consideration for the issue hereof, expressly waived and released.

     The Securities of this series are subject to defeasance at the option of the Company as
provided in the Indenture.

     All terms used in this Security which are defined in the Indenture shall have the meanings
assigned to them in the Indenture.

 

 

     IN WITNESS WHEREOF, the Company has caused this instrument to be duly executed under its
corporate seal.

	 	 	 	 	 
	Dated: February 14, 2011 	CNA FINANCIAL CORPORATION

 	 
	 	By:  	 	 
	 	 	Name:  	D. Craig Mense 	 
	 	 	Title:  	Executive Vice President and

Chief Financial Officer 	 
	 

[SEAL]

	 	 	 	 	 
	 	Attest:

 	 
	 	By:  	 	 
	 	 	Name:  	Mary A. Ribikawskis 	 
	 	 	Title:  	Assistant Vice President and

Assistant Secretary 	 
	 

     This is one of the Securities of the series designated herein and referred to in the
within-mentioned Indenture.

	 	 	 	 	 
	Dated: February 14, 2011 	THE BANK OF NEW YORK MELLON TRUST 

COMPANY, N.A.,as Trustee

 	 
	 	By:  	 	 
	 	 	Authorized Officer 	 
	 	 	 	 
	 

[Signature Page to Global Note]

 

 

 

ABBREVIATIONS

     The following abbreviations, when used in the inscription on the face of this instrument,
shall be construed as though they were written out in full according to applicable laws or
regulations:

TEN COM — as tenants in common

TEN ENT — as tenants by the entireties

JT TEN  — as joint tenants with right of survivorship and not as tenants in common

	 	 	 

	UNIF GIFT MIN ACT -

	 	.................. Custodian .............

(Cust)                         (Minor)

Under Uniform Gifts to Minors Act

	 

	 	...................................................

                
  (State)

Additional abbreviations may also be used though not in the above list. 

     FOR VALUE RECEIVED, the undersigned hereby sell(s), assign(s) and transfer(s) unto

PLEASE INSERT SOCIAL SECURITY OR

OTHER IDENTIFYING NUMBER OF ASSIGNEE

	 	 	 	 	 	 

	 	 

	 	 	 	 
	 

PLEASE PRINT OR TYPEWRITE NAME AND ADDRESS INCLUDING POSTAL ZIP CODE OF ASSIGNEE

 

the within Security and all rights thereunder, hereby irrevocably constituting and appointing       
                
attorney to transfer said Security on the books of the Company, with
full power of substitution in the premises.

Dated:

 

Signature

NOTICE: THE SIGNATURE TO THIS ASSIGNMENT MUST CORRESPOND WITH THE NAME AS WRITTEN UPON THE FACE OF
THE WITHIN INSTRUMENT IN EVERY PARTICULAR, WITHOUT ALTERATION OR ENLARGEMENT OR ANY CHANGE
WHATEVER.

THE SIGNATURE(S) MUST BE GUARANTEED BY AN “ELIGIBLE GUARANTOR INSTITUTION” THAT IS A MEMBER OR
PARTICIPANT IN A “SIGNATURE GUARANTEE PROGRAM” (E.G., THE SECURITIES TRANSFER AGENTS MEDALLION
PROGRAM, THE STOCK EXCHANGE MEDALLION PROGRAM OR THE NEW YORK STOCK EXCHANGE, INC. MEDALLION
SIGNATURE PROGRAM).

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00184-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00184-of-00352.parquet"}]]